Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2025-12-26 @ 12:43 AM
NCT ID:
NCT03373760
Group ID:
EG000
Title:
MEDI4736 + Tremelimumab
Description:
Participants receive tremelimumab and durvalumab on day 1 of each 28-day cycle for four cycles. Starting at cycle 5, participants receive durvalumab on day 1 of each cycle until disease progression or unacceptable toxicity.
Tremelimumab: Given IV Durvalumab: Given IV
Deaths Number Affected:
47
Deaths Number At Risk:
None
Serious Number Affected:
36
Serious Number At Risk:
58
Other Number Affected:
58
Other Number At Risk:
58
Study:
NCT03373760
Results Section:
NCT03373760
Adverse Events Module:
NCT03373760